Wilson Sonsini Goodrich & Rosati advised Valdera on the transaction. Valdera, an AI-driven sourcing platform for chemicals and raw materials, announced securing $15 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aytu BioPharma on the transaction. Aytu BioPharma, Inc. (the “Company” or “Aytu”) (Nasdaq:AYTU) and Lupin Pharma Canada Ltd (“Lupin”), a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised 858 Therapeutics on intellectual property matters related to the transaction. 858 Therapeutics announced raising $50 million in a Series B...
You must be a Standard 1 Year member to access this content.
Sidley Austin is advising Ridgeview Partners on the transaction, and Wilson, Sonsini, Goodrich & Rosati is advising PayRange. Ridgeview Partners, a growth-oriented technology private equity firm,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Featurespace in the deal. Visa (NYSE: V) announced it has signed a definitive agreement to acquire Featurespace, a developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clearway on the transaction. Clearway Energy Group (“Clearway”) announced that it has closed $550 million in construction financing and started...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vertos Medical Inc. on the transaction. Stryker (NYSE: SYK), a global leader in medical technologies, announced a definitive agreement to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Upstart in the transaction. Upstart Holdings, Inc. (NASDAQ: UPST) announced it completed an upsized offering of $431.25 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised FluoRok on patent matters related to the transaction. FluoRok, a deep-tech start-up focused on fluorochemical manufacturing, announced the completion of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Sanofi in the transaction, and Wilson Sonsini Goodrich & Rosati represented Ventyx Biosciences, Inc. Sanofi announced a $27 million strategic investment in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction. GC Therapeutics (GCTx), a biopharmaceutical company, announced its launch and the completion of a $65...
You must be a Standard 1 Year member to access this content.
